By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bionomics Limited 

31 Dalgleish Street

Thebarton  South Australia  5031  Australia
Phone: 618-8354-6100 Fax: 618-8354-6199




Nanogen, Inc.  Epilepsy diagnostic product development

Genmab A/S  Anti-angiogenesis therapeutic antibody development

Univ. of Melbourne, Women's & Children's Hospital 

Brigham and Women's Hospital 

Howard Florey Institute 

Company News
Bionomics Limited (BNO.AX) Begins Trading On OTCQX Marketplace 3/2/2015 7:42:13 AM
Bionomics Limited (BNO.AX) Release: New BNC105 Biomarker Data To Be Presented At US Cancer Conference 2/27/2015 9:54:03 AM
Bionomics Limited (BNO.AX) Begins Phase 1b Study With Anxiety Drug Bnc210 2/2/2015 9:22:23 AM
Bionomics Limited (BNO.AX) Release: BNC101 Data To Be Presented At European Cancer Conference 11/21/2014 2:51:21 PM
Bionomics Limited (BNO.AX) To Present BNC210 At Society For Neuroscience Meeting 11/17/2014 2:36:58 PM
Bionomics Limited (BNO.AX) To Progress BNC210 In Clinical Trials 11/11/2014 7:22:21 AM
Bionomics Limited (BNO.AX) Presents BNC105 Phase 2 Renal Cancer Trial Biomarker Data 9/29/2014 8:59:35 AM
Bionomics Limited (BNO.AX) Receives $7.5M 2014 R&D Tax Incentive 9/5/2014 8:15:41 AM
Bionomics Limited (BNO.AX) Clinches Alzheimer's Research And Funding Deal With Merck & Co., Inc. (MRK) Worth Up To $526 Million 6/24/2014 1:43:45 AM
Bionomics Limited (BNO.AX) Features At American Association for Cancer Research Annual Meeting 4/7/2014 9:10:08 AM